Medizinischer Sauerstoff, Gasförmig Vivisol (Oxygen)

When inhaled, oxygen diffuses across the alveolar membrane into the bloodstream, increasing the partial pressure of oxygen (PaO₂). This raises hemoglobin saturation, allowing more oxygen to be transported to tissues where it supports cellular metabolism and reduces hypoxic injury.

The prescribed dose is set by the treating clinician based on the patient’s oxygen saturation, underlying condition, and clinical response. Dosage is expressed as flow rate (e.g., liters per minute) and concentration, and it is adjusted according to ongoing monitoring.

Oxygen therapy is generally considered safe in pregnancy and lactation when medically indicated, but the decision rests with the healthcare provider. No specific teratogenic risk is known, yet the prescriber will weigh benefits against any potential concerns.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medizinischer Sauerstoff, Gasförmig Vivisol is a compressed medical‑grade oxygen gas meeting EU standards. Compared with liquid oxygen systems, it offers easier handling and storage at ambient temperature, while providing comparable purity and flow‑rate control for clinical use.

Store cylinders at ambient temperature, upright, in a well‑ventilated area away from heat sources, direct sunlight and open flames. Keep the regulator protected, ensure cylinder valves are closed when not in use, and follow local regulations for medical gas storage.

The gas is delivered from a high‑pressure cylinder through a regulator and appropriate delivery device such as a nasal cannula, simple face mask, or non‑rebreather mask. The prescriber sets the flow rate according to the patient’s oxygenation needs.

Serious risks include fire or explosion when oxygen contacts ignition sources, pulmonary oxygen toxicity from prolonged high‑concentration exposure, and central nervous system toxicity (seizures). Proper monitoring and adherence to safety protocols are essential to mitigate these hazards.

Patients with certain conditions such as severe chronic hypercapnia (e.g., some COPD patients) who may retain carbon dioxide, or those with contraindications to high‑flow oxygen, should avoid use unless closely monitored by a qualified clinician.